HEMATOXYLIN

HEMATOXYLIN is a lipid of Polyketides (PK) class. Hematoxylin is associated with abnormalities such as Eosinophilia, Duodenal Adenoma, Senile Plaques, Morphologically altered structure and Cervical abscess. The involved functions are known as Uptake, Apoptosis, Amplification, Necrosis and Karyopyknosis. Hematoxylin often locates in Body tissue, Extracellular, Compact bone, Skin and Basement membrane. The associated genes with HEMATOXYLIN are GAPDH gene, Genome, Elastin, MERTK wt Allele and P4HTM gene.

Cross Reference

Introduction

To understand associated biological information of HEMATOXYLIN, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with HEMATOXYLIN?

HEMATOXYLIN is suspected in Senile Plaques, Eosinophilia, Duodenal Adenoma, Morphologically altered structure, Cervical abscess and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with HEMATOXYLIN

MeSH term MeSH ID Detail
Intracranial Embolism and Thrombosis D002542 5 associated lipids
Brain Ischemia D002545 89 associated lipids
Uterine Cervical Neoplasms D002583 10 associated lipids
Choroid Neoplasms D002830 2 associated lipids
Coccidioidomycosis D003047 2 associated lipids
Colonic Neoplasms D003110 161 associated lipids
Colorectal Neoplasms, Hereditary Nonpolyposis D003123 2 associated lipids
Conjunctival Neoplasms D003230 3 associated lipids
Coronary Disease D003327 70 associated lipids
Congenital Hypothyroidism D003409 1 associated lipids
Per page 10 20 50 100 | Total 146

PubChem Associated disorders and diseases

What pathways are associated with HEMATOXYLIN

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with HEMATOXYLIN?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with HEMATOXYLIN?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

What genes are associated with HEMATOXYLIN?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with HEMATOXYLIN?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with HEMATOXYLIN

Download all related citations
Per page 10 20 50 100 | Total 5340
Authors Title Published Journal PubMed Link
Seshadri T et al. Lack of evidence of disease contamination in ovarian tissue harvested for cryopreservation from patients with Hodgkin lymphoma and analysis of factors predictive of oocyte yield. 2006 Br. J. Cancer pmid:16570049
Barshishat M et al. Butyrate down-regulates CD44 transcription and liver colonisation in a highly metastatic human colon carcinoma cell line. 2002 Br. J. Cancer pmid:12439723
Mizunuma H et al. The LIM-only protein, LMO4, and the LIM domain-binding protein, LDB1, expression in squamous cell carcinomas of the oral cavity. 2003 Br. J. Cancer pmid:12771919
Bradley G et al. The expression of p53-induced protein with death domain (Pidd) and apoptosis in oral squamous cell carcinoma. 2007 Br. J. Cancer pmid:17437012
Beau-Faller M et al. Detection of K-Ras mutations in tumour samples of patients with non-small cell lung cancer using PNA-mediated PCR clamping. 2009 Br. J. Cancer pmid:19293811
Sundar SS et al. Role of lymphangiogenesis in epithelial ovarian cancer. 2006 Br. J. Cancer pmid:16685274
Beskow C et al. Expression of DNA damage response proteins and complete remission after radiotherapy of stage IB-IIA of cervical cancer. 2006 Br. J. Cancer pmid:16685270
Mekenkamp LJ et al. Clinicopathological features and outcome in advanced colorectal cancer patients with synchronous vs metachronous metastases. 2010 Br. J. Cancer pmid:20551951
Ishikawa K et al. Mitotic centromere-associated kinesin is a novel marker for prognosis and lymph node metastasis in colorectal cancer. 2008 Br. J. Cancer pmid:18506187
Bilim V et al. Glycogen synthase kinase-3: a new therapeutic target in renal cell carcinoma. 2009 Br. J. Cancer pmid:19920820
Trinh XB et al. The VEGF pathway and the AKT/mTOR/p70S6K1 signalling pathway in human epithelial ovarian cancer. 2009 Br. J. Cancer pmid:19240722
van Etten B et al. Degree of tumour vascularity correlates with drug accumulation and tumour response upon TNF-alpha-based isolated hepatic perfusion. 2003 Br. J. Cancer pmid:12610519
Graff BA et al. Intratumour heterogeneity in the uptake of macromolecular therapeutic agents in human melanoma xenografts. 2003 Br. J. Cancer pmid:12610516
Kristiansen G et al. CD24 is an independent prognostic marker of survival in nonsmall cell lung cancer patients. 2003 Br. J. Cancer pmid:12610508
Liu J et al. Adenovirus-mediated hypoxia-targeting cytosine deaminase gene therapy enhances radiotherapy in tumour xenografts. 2007 Br. J. Cancer pmid:17519901
Townsley CA et al. Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer. 2006 Br. J. Cancer pmid:16570047
Baldewijns MM et al. High-grade clear cell renal cell carcinoma has a higher angiogenic activity than low-grade renal cell carcinoma based on histomorphological quantification and qRT-PCR mRNA expression profile. 2007 Br. J. Cancer pmid:17505508
Suzuki S et al. MAGE-A protein and MAGE-A10 gene expressions in liver metastasis in patients with stomach cancer. 2008 Br. J. Cancer pmid:18594524
Shrout J et al. beta(2)microglobulin mRNA expression levels are prognostic for lymph node metastasis in colorectal cancer patients. 2008 Br. J. Cancer pmid:18506145
Griffiths EA et al. Increasing expression of hypoxia-inducible proteins in the Barrett's metaplasia-dysplasia-adenocarcinoma sequence. 2007 Br. J. Cancer pmid:17437013
Kronqvist P et al. Morphometrical malignancy grading is a valuable prognostic factor in invasive ductal breast cancer. 2002 Br. J. Cancer pmid:12439717
Barker SE et al. Immunotherapy for neuroblastoma using syngeneic fibroblasts transfected with IL-2 and IL-12. 2007 Br. J. Cancer pmid:17595664
Tomlinson VA et al. Expression of eEF1A2 is associated with clear cell histology in ovarian carcinomas: overexpression of the gene is not dependent on modifications at the EEF1A2 locus. 2007 Br. J. Cancer pmid:17437010
Oei AL et al. Surveillance of women at high risk for hereditary ovarian cancer is inefficient. 2006 Br. J. Cancer pmid:16495917
Onda T et al. Ubiquitous mitochondrial creatine kinase downregulated in oral squamous cell carcinoma. 2006 Br. J. Cancer pmid:16479256
Pritchard-Jones RO et al. Expression of VEGF(xxx)b, the inhibitory isoforms of VEGF, in malignant melanoma. 2007 Br. J. Cancer pmid:17595666
Wang Y et al. Tissue microarray analysis of human FRAT1 expression and its correlation with the subcellular localisation of beta-catenin in ovarian tumours. 2006 Br. J. Cancer pmid:16479254
Yao M et al. COX-2 selective inhibition reverses the trophic properties of gastrin in colorectal cancer. 2002 Br. J. Cancer pmid:12189559
Wülfing P et al. Expression of endothelin-A-receptor predicts unfavourable response to neoadjuvant chemotherapy in locally advanced breast cancer. 2004 Br. J. Cancer pmid:15226779
Lawson MH et al. Bcl-2 and β1-integrin predict survival in a tissue microarray of small cell lung cancer. 2010 Br. J. Cancer pmid:21063403
Løvig T et al. Strong HLA-DR expression in microsatellite stable carcinomas of the large bowel is associated with good prognosis. 2002 Br. J. Cancer pmid:12232760
Ben-Izhak O et al. TUNEL - an efficient prognosis predictor of salivary malignancies. 2007 Br. J. Cancer pmid:17325701
Zou L et al. Profilin-1 is a negative regulator of mammary carcinoma aggressiveness. 2007 Br. J. Cancer pmid:17940506
Heng B et al. Human papilloma virus is associated with breast cancer. 2009 Br. J. Cancer pmid:19724278
Griffiths EA et al. Hypoxia-associated markers in gastric carcinogenesis and HIF-2alpha in gastric and gastro-oesophageal cancer prognosis. 2008 Br. J. Cancer pmid:18283323
Campbell L et al. Combined expression of caveolin-1 and an activated AKT/mTOR pathway predicts reduced disease-free survival in clinically confined renal cell carcinoma. 2008 Br. J. Cancer pmid:18283322
Mc Cormack O et al. Growth arrest-specific gene 6 expression in human breast cancer. 2008 Br. J. Cancer pmid:18283315
Bilim V et al. Double inhibition of XIAP and Bcl-2 axis is beneficial for retrieving sensitivity of renal cell cancer to apoptosis. 2008 Br. J. Cancer pmid:18283311
Slade MJ et al. Comparison of bone marrow, disseminated tumour cells and blood-circulating tumour cells in breast cancer patients after primary treatment. 2009 Br. J. Cancer pmid:19034279
Wang W et al. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis. 2004 Br. J. Cancer pmid:15150600
Carlsson J et al. HER2 expression in breast cancer primary tumours and corresponding metastases. Original data and literature review. 2004 Br. J. Cancer pmid:15150568
Hong AM et al. Human papillomavirus predicts outcome in oropharyngeal cancer in patients treated primarily with surgery or radiation therapy. 2010 Br. J. Cancer pmid:20959828
Tørring N et al. Genome-wide analysis of allelic imbalance in prostate cancer using the Affymetrix 50K SNP mapping array. 2007 Br. J. Cancer pmid:17245344
Yun JP et al. Increased expression of nucleophosmin/B23 in hepatocellular carcinoma and correlation with clinicopathological parameters. 2007 Br. J. Cancer pmid:17245342
van Etten B et al. Prerequisites for effective adenovirus mediated gene therapy of colorectal liver metastases in the rat using an intracellular neutralizing antibody fragment to p21-Ras. 2002 Br. J. Cancer pmid:11875712
Beskow C et al. Radioresistant cervical cancer shows upregulation of the NHEJ proteins DNA-PKcs, Ku70 and Ku86. 2009 Br. J. Cancer pmid:19672258
Kuefer R et al. Sodium butyrate and tributyrin induce in vivo growth inhibition and apoptosis in human prostate cancer. 2004 Br. J. Cancer pmid:14735205
Bing C et al. Expression of uncoupling proteins-1, -2 and -3 mRNA is induced by an adenocarcinoma-derived lipid-mobilizing factor. 2002 Br. J. Cancer pmid:11870545
Dales JP et al. Prediction of metastasis risk (11 year follow-up) using VEGF-R1, VEGF-R2, Tie-2/Tek and CD105 expression in breast cancer (n=905). 2004 Br. J. Cancer pmid:15026804
Nakayama K et al. Allelic loss at 19q12 and Xq11-12 predict an adverse clinical outcome in patients with mucinous ovarian tumours of low malignant potential. 2004 Br. J. Cancer pmid:15026802
Lee KT et al. Overexpression of Id-1 is significantly associated with tumour angiogenesis in human pancreas cancers. 2004 Br. J. Cancer pmid:15026801
Bradley G et al. Abnormal DNA content in oral epithelial dysplasia is associated with increased risk of progression to carcinoma. 2010 Br. J. Cancer pmid:20859287
Duda DG et al. Overexpression of the p53-inducible brain-specific angiogenesis inhibitor 1 suppresses efficiently tumour angiogenesis. 2002 Br. J. Cancer pmid:11875720
Millis RR et al. Occult axillary lymph node metastases are of no prognostic significance in breast cancer. 2002 Br. J. Cancer pmid:11875706
Page K et al. Detection of HER2 amplification in circulating free DNA in patients with breast cancer. 2011 Br. J. Cancer pmid:21427727
Fontanini G et al. A high vascular count and overexpression of vascular endothelial growth factor are associated with unfavourable prognosis in operated small cell lung carcinoma. 2002 Br. J. Cancer pmid:11870537
Davidson EJ et al. Minichromosome maintenance (Mcm) proteins, cyclin B1 and D1, phosphohistone H3 and in situ DNA replication for functional analysis of vulval intraepithelial neoplasia. 2003 Br. J. Cancer pmid:12610511
Duanmu J et al. Effective treatment of chemoresistant breast cancer in vitro and in vivo by a factor VII-targeted photodynamic therapy. 2011 Br. J. Cancer pmid:21427724
Rosenthal AN et al. Immunohistochemical analysis of p53 in vulval intraepithelial neoplasia and vulval squamous cell carcinoma. 2003 Br. J. Cancer pmid:12610510
Terry G et al. Abnormal FHIT expression profiles in cervical intraepithelial neoplastic (CIN) lesions. 2002 Br. J. Cancer pmid:11875703
Bruynzeel AM et al. Anti-inflammatory agents and monoHER protect against DOX-induced cardiotoxicity and accumulation of CML in mice. 2007 Br. J. Cancer pmid:17325706
Cai H et al. Growth-inhibitory and cell cycle-arresting properties of the rice bran constituent tricin in human-derived breast cancer cells in vitro and in nude mice in vivo. 2004 Br. J. Cancer pmid:15316567
Bluff JE et al. Angiogenesis is associated with the onset of hyperplasia in human ductal breast disease. 2009 Br. J. Cancer pmid:19623180
Hofer MD et al. Expression of MTA1 promotes motility and invasiveness of PANC-1 pancreatic carcinoma cells. 2004 Br. J. Cancer pmid:14735193
Hernes E et al. Expression of the epidermal growth factor receptor family in prostate carcinoma before and during androgen-independence. 2004 Br. J. Cancer pmid:14735192
Gu C et al. Low expression of polypeptide GalNAc N-acetylgalactosaminyl transferase-3 in lung adenocarcinoma: impact on poor prognosis and early recurrence. 2004 Br. J. Cancer pmid:14735190
Ito Y et al. Polo-like kinase 1 overexpression is an early event in the progression of papillary carcinoma. 2004 Br. J. Cancer pmid:14735186
Shaw RJ et al. Cytoglobin is upregulated by tumour hypoxia and silenced by promoter hypermethylation in head and neck cancer. 2009 Br. J. Cancer pmid:19568272
Zheng HC et al. Upregulated EMMPRIN/CD147 might contribute to growth and angiogenesis of gastric carcinoma: a good marker for local invasion and prognosis. 2006 Br. J. Cancer pmid:17088917
Sheach LA et al. Androgen-related expression of G-proteins in ovarian cancer. 2009 Br. J. Cancer pmid:19623182
Cemazar M et al. The endothelin B (ETB) receptor agonist IRL 1620 is highly vasoconstrictive in two syngeneic rat tumour lines: potential for selective tumour blood flow modification. 2005 Br. J. Cancer pmid:15970923
Lee JW et al. BRAF mutations in non-Hodgkin's lymphoma. 2003 Br. J. Cancer pmid:14612909
Oehler MK et al. Tissue and plasma expression of the angiogenic peptide adrenomedullin in breast cancer. 2003 Br. J. Cancer pmid:14612905
Campbell L et al. Caveolin-1 overexpression predicts poor disease-free survival of patients with clinically confined renal cell carcinoma. 2003 Br. J. Cancer pmid:14612902
Bromwich EJ et al. The relationship between T-lymphocyte infiltration, stage, tumour grade and survival in patients undergoing curative surgery for renal cell cancer. 2003 Br. J. Cancer pmid:14612901
Kawaraya M et al. Evaluation of various cytological examinations by bronchoscopy in the diagnosis of peripheral lung cancer. 2003 Br. J. Cancer pmid:14612897
El-Emir E et al. Characterisation and radioimmunotherapy of L19-SIP, an anti-angiogenic antibody against the extra domain B of fibronectin, in colorectal tumour models. 2007 Br. J. Cancer pmid:17519905
Kohno Y et al. Expression of Y-box-binding protein dbpC/contrin, a potentially new cancer/testis antigen. 2006 Br. J. Cancer pmid:16479255
Negishi T et al. NK105, a paclitaxel-incorporating micellar nanoparticle, is a more potent radiosensitising agent compared to free paclitaxel. 2006 Br. J. Cancer pmid:16909136
Vlahovic G et al. Treatment with Imatinib in NSCLC is associated with decrease of phosphorylated PDGFR-beta and VEGF expression, decrease in interstitial fluid pressure and improvement of oxygenation. 2006 Br. J. Cancer pmid:17003785
Almstrup K et al. Genome-wide gene expression profiling of testicular carcinoma in situ progression into overt tumours. 2005 Br. J. Cancer pmid:15856041
Sarbia M et al. The predictive value of molecular markers (p53, EGFR, ATM, CHK2) in multimodally treated squamous cell carcinoma of the oesophagus. 2007 Br. J. Cancer pmid:17940507
Lujan B et al. Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands. 2010 Br. J. Cancer pmid:20664595
Dufresne A et al. Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis. 2010 Br. J. Cancer pmid:20664593
Chatrath P et al. Aberrant expression of minichromosome maintenance protein-2 and Ki67 in laryngeal squamous epithelial lesions. 2003 Br. J. Cancer pmid:12966424
Kurokawa T et al. Overexpression of hypoxia-inducible-factor 1alpha(HIF-1alpha) in oesophageal squamous cell carcinoma correlates with lymph node metastasis and pathologic stage. 2003 Br. J. Cancer pmid:12966423
Lau ST et al. Role of reactive oxygen species in brucein D-mediated p38-mitogen-activated protein kinase and nuclear factor-kappaB signalling pathways in human pancreatic adenocarcinoma cells. 2010 Br. J. Cancer pmid:20068565
Cellai I et al. In vivo effects of rosiglitazone in a human neuroblastoma xenograft. 2010 Br. J. Cancer pmid:20068562
Span PN et al. Carbonic anhydrase-9 expression levels and prognosis in human breast cancer: association with treatment outcome. 2003 Br. J. Cancer pmid:12865916
Mori N et al. Expression of HER-2 affects patient survival and paclitaxel sensitivity in endometrial cancer. 2010 Br. J. Cancer pmid:20664599
Suzuki M et al. Aberrant methylation of SPARC in human lung cancers. 2005 Br. J. Cancer pmid:15756262
Cappello F et al. CD1a expression by Barrett's metaplasia of gastric type may help to predict its evolution towards cancer. 2005 Br. J. Cancer pmid:15756258
Hsiao JR et al. Constitutive activation of STAT3 and STAT5 is present in the majority of nasopharyngeal carcinoma and correlates with better prognosis. 2003 Br. J. Cancer pmid:12865928
Fukushima N et al. Aberrant methylation of suppressor of cytokine signalling-1 (SOCS-1) gene in pancreatic ductal neoplasms. 2003 Br. J. Cancer pmid:12865927
Chang YL et al. Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancers. 2003 Br. J. Cancer pmid:12865924
Benharroch D et al. Measles virus: evidence of an association with Hodgkin's disease. 2004 Br. J. Cancer pmid:15226778
Bach SP et al. Regional localisation of p53-independent apoptosis determines toxicity to 5-fluorouracil and pyrrolidinedithiocarbamate in the murine gut. 2006 Br. J. Cancer pmid:16804527
Carpi A et al. Large needle aspiration biopsy and galectin-3 determination in selected thyroid nodules with indeterminate FNA-cytology. 2006 Br. J. Cancer pmid:16804521
Attard G et al. Heterogeneity and clinical significance of ETV1 translocations in human prostate cancer. 2008 Br. J. Cancer pmid:18594527
Nomura S et al. FGF10/FGFR2 signal induces cell migration and invasion in pancreatic cancer. 2008 Br. J. Cancer pmid:18594526